LJM1R — Latvijas Juras Medicinas Centrs AS Income Statement
0.000.00%
Last trade - 00:00
- €6.40m
- €5.73m
- €9.84m
- 27
- 65
- 14
- 25
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | Interim Report | ARS | ARS | ARS |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.27 | 7.08 | 9.36 | 9.7 | 9.84 |
Cost of Revenue | |||||
Gross Profit | 0.455 | 0.593 | 1.22 | 0.775 | 0.376 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.11 | 6.81 | 8.48 | 9.07 | 9.85 |
Operating Profit | 0.165 | 0.275 | 0.881 | 0.626 | -0.014 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.165 | 0.275 | 0.881 | 0.626 | -0.014 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.164 | 0.274 | 0.88 | 0.626 | -0.014 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.164 | 0.274 | 0.88 | 0.626 | -0.014 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.164 | 0.274 | 0.88 | 0.626 | -0.014 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.193 | 0.33 | 1.09 | 0.784 | -0.012 |
Dividends per Share |